BOC vs RHEP
Boston Omaha Corp. and Regional Health Properties, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | BOC | RHEP |
|---|---|---|
| Revenue | $114.4M | $53.2M |
| Net income | $-12.4M | $3.4M |
| Gross margin | 65.8% | 86.9% |
| Net margin | −16.0% | 6.3% |
| Return on equity | −2.4% | · |
| Diluted EPS | −$0.40 | $1.09 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | $-10.0M | $-3.1M |
| Equity | $516.1M | $349,000 |
| Net debt / equity | 0.04× | 106.45× |
| Current ratio | 1.98× | 0.67× |
| Revenue CAGR 5y | 20.1% | 24.8% |
| Profit CAGR 5y | · | · |
BOC bills 2.2× the revenue of RHEP, and BOC closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | BOC | RHEP |
|---|---|---|
| FY2025 | $114.4M | $53.2M |
| FY2024 | $108.3M | $18.3M |
| FY2023 | $96.3M | $17.2M |
| FY2022 | $81.2M | $35.9M |
| FY2021 | $57.0M | $26.7M |
| FY2020 | $45.7M | $17.6M |
| FY2019 | $41.4M | $20.1M |
| FY2018 | $20.0M | $22.0M |
| FY2017 | $9.0M | $25.1M |
| FY2016 | $3.8M | $27.6M |
Bottom line
| Fiscal year | BOC | RHEP |
|---|---|---|
| FY2025 | $-12.4M | $3.4M |
| FY2024 | $-1.3M | $-3.2M |
| FY2023 | $-7.0M | $-3.9M |
| FY2022 | $10.2M | $-6.9M |
| FY2021 | $52.7M | $-1.2M |
| FY2020 | $-49,089 | $-688,000 |
| FY2019 | $-1.5M | $5.5M |
| FY2018 | $-9.1M | $-11.9M |
| FY2017 | $-6.5M | $-985,000 |
| FY2016 | $-3.2M | $-7.5M |
14 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$61,216,348 | BOC |
| FY2024 | +$89,939,901 | BOC |
| FY2023 | +$79,089,736 | BOC |
| FY2022 | +$45,309,194 | BOC |
| FY2021 | +$30,281,811 | BOC |
| FY2020 | +$28,164,463 | BOC |
| FY2019 | +$21,255,138 | BOC |
| FY2018 | −$2,024,607 | RHEP |
| FY2017 | −$16,133,655 | RHEP |
| FY2016 | −$23,757,483 | RHEP |
| FY2015 | −$17,677,088 | RHEP |
| FY2014 | −$3,281,126 | RHEP |
| FY2013 | −$185,716,451 | RHEP |
| FY2012 | −$193,971,878 | RHEP |
The higher-revenue side has changed between BOC and RHEP over this period. The gap has narrowed since the earliest year compared.
14 of 16 comparable fiscal years — a year missing data on either side is not counted.
12 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −22.3 pp | RHEP |
| FY2024 | +20.7 pp | BOC |
| FY2023 | +16.2 pp | BOC |
| FY2022 | +31.9 pp | BOC |
| FY2021 | +101.8 pp | BOC |
| FY2020 | −1.4 pp | RHEP |
| FY2019 | −30.9 pp | RHEP |
| FY2018 | +8.2 pp | BOC |
| FY2017 | −68.0 pp | RHEP |
| FY2016 | −55.5 pp | RHEP |
| FY2015 | −21.5 pp | RHEP |
| FY2012 | −86.8 pp | RHEP |
The higher net margin has changed hands between BOC and RHEP over this period.
12 of 15 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
BOC's net margin has been more volatile than RHEP's over the 12 comparable fiscal years — 59.8 percentage points of standard deviation against 36.3.
12 of 15 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between BOC and RHEP over these 12 fiscal years — BOC led in 5 and RHEP in 7.
12 of 15 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
RHEP's return on equity has been more volatile than BOC's over the 6 comparable fiscal years — 84.1 percentage points of standard deviation against 5.1.
6 of 14 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between BOC and RHEP over these 6 fiscal years — BOC led in 5 and RHEP in 1.
6 of 14 comparable fiscal years — a year missing data on either side is not counted.